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Copyright © 2008 JCBN Summary Helicobacter pylori (H. pylori) is one of the most widespread human pathogens, and
plays major roles in chronic gastritis and gastric cancer. CD74 of gastric epithelial cells has
recently been identified as an adhesion molecule to urease in H. pylori. In this study, we found
that CD74 is highly expressed in a constitutive manner in NCI-N87 human gastric carcinoma
cells at both the protein and mRNA levels as compared with Hs738St./Int fetal gastric cells.
Subsequently, a novel cell-based ELISA able to rapidly screen the suppressive agents of CD74
expression was established. NCI-N87 cells were treated separately with 25 different food
phytochemicals (4–100 µM) for 48 h and subjected to our novel assay. From those results, a
citrus coumarin, bergamottin, was indicated to be the most promising compound with an LC50/
IC50 value greater than 7.1, followed by luteolin (>5.4), nobiletin (>5.3), and quercetin (>5.1).
Our findings suggest that these CD74 suppressants are unique candidates for preventing
H. pylori adhesion and subsequent infection with reasonable action mechanisms.
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Introduction
Helicobacter pylori (H. pylori), which infects over half of
all people in the world, is one of the most widespread human
pathogens and responsible for chronic gastritis, and gastric
and duodenal ulcers [1,  2]. In 1994, the organism was
classified into group I, “carcinogenic to humans,” by the
World Health Organization/International Agency for Re-
search on Cancer (WHO/IARC) [3]. Although triple therapy
using two antibiotics (amoxicillin and clarithromycin) and a
proton pump inhibitor is widely employed for the treatment
of H. pylori, antibiotic resistance to clarithromycin leads to
treatment failure, especially in Asian countries [4, 5].
A number of food extracts and components have been
shown to relieve the risk of damage from H. pylori infection.
In Mongolian gerbils, green tea catechins, such as (–)-
epigallocatechin-3-gallate (EGCG), strongly inhibited H.
pylori  urease activity in vitro and suppressed H. pylori-
induced gastritis [6], while garlic and its diallyl sulfur
compounds showed potential effects on H. pylori elimina-
tion [7]. However, these phytochemicals are yet to be proven
effective enough for clinical use on account of their broad
range of biological activities, thus more specific molecular
targeting is indispensable to conquer this problem.
The adhesion of H. pylori to gastric cells is one of the
critical steps in gastritis, which leads to release of the
definitive virulence factor cytotoxin-associated antigen A
(CagA) [8]. However, the adhesion mechanisms of H. pylori
to gastric epithelial cells are not fully understood. Recently,H. Sekiguchi et al.
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CD74 was detected on gastric epithelial cells and shown to
be an adhesion molecule to urease in H. pylori [9], a 5–10%
bacterial whole protein that is expressed in all strains [10].
This enzyme catalyzes the hydrolysis of urea to produce
ammonia and carbon dioxide, while its most crucial role is to
buffer the bacteria from the acidic environment of the
stomach [11]. Therefore, it is considered that H. pylori
urease is essential for bacterial colonization. Urease consists
of two subunits, i.e., the α-subunit at approximately 24 kDa
and β-subunit at approximately 68 kDa [10]. Beswick et al.
suggested that the urease β-subunit binds to CD74 on gastric
epithelial cells and induces nuclear factor-kappa B (NF-κB)
activation, thereby stimulating interleukin-8 (IL-8) produc-
tion [9, 12]. This raises the possibility that CD74-mediated
H. pylori adhesion is a critical step for gastritis and resultant
carcinogenesis.
In this study, we investigated the levels of constitutive
CD74 expression in N87 gastric carcinoma cells and
Hs738St./Int fetal gastric cells, then established a novel cell-
based ELISA for CD74 semi-quantification. Our results
identified bergamottin, a coumarin-related compound in
citrus fruit, as the most promising agent after screening a
total of 25 food phytochemicals.
Materials and Methods
Chemicals
RPMI1640, Dulbecco’s modified eagle medium (DMEM),
and fetal bovine serum (FBS) were purchased from Gibco
BRL (Grand Island, NY). Oligonucleotide primers were
synthesized by Sigma-Aldrich (Tokyo, Japan). TRIzol®
reagent was from Qiagen (Hilden, Germany). An RNA
polymerase chain reaction (PCR) Kit (AMV, Ver. 2.1) came
from TaKaRa Bio (Shiga, Japan). Nonspecific IgG, used as a
negative control, was purchased from Dako (Glostrup,
Denmark). Antibodies were purchased from the following
sources: rabbit anti-CD74 was from Santa Cruz Bio-
technology Inc. (Santa Cruz, CA), α-tublin came from
Calbiochem (San Diego, CA), and anti-rabbit IgG was ob-
tained from Dako (Glostrup, Denmark). 1'-Acetoxychavicol
acetate (ACA) [13], zerumbone [14], auraptene [15], nobi-
letin [16], and ar-turmerone [17] were isolated as previously
described. PEITC (phenetyl isothiocyanate) and BUITC
(butenyl isothiocyate) were purchased from Tokyo Chemical
Industry (Tokyo, Japan). Both PEGLS and BUGLS were
purified using a method reported by Barillari et al. [18], then
used following a few modifications. Barbarea verna seeds
were extracted with boiling water, then the extract was
obtained by centrifugation, deproteinized by addition of 1 M
Zn(OAc)2, and centrifuged, after which the supernatant was
subjected to chromatography with a DEAE-Sephadex A-25.
The concentrated fraction was extracted with boiling
methanol and the extract was centrifuged. The supernatant
was added to chilled ethanol and gluconasturtiin (PUGLS)
was obtained as a white powder after centrifugation.
Gluconapin (BUGLS) was isolated from Brassica rapa L.
(Yamato-mana) seeds in the same manner described above.
All other chemicals were purchased from Wako Pure
Chemicals (Osaka, Japan), unless specified otherwise.
Cell culture
NCI-N87 gastric carcinoma and Hs738St./Int fetal gastric
cells were obtained from American Type Culture Collection
(Rockville, MD), and grown in RPMI 1640 and DMEM,
respectively, supplemented with 10% FBS, penicillin
(100 U/ml), and streptomycin (100 μg/ml) at 37°C under a
humidified atmosphere of 95% air and 5% CO2.
Western blotting
Cells (3.4 × 105 cells/1.7 ml on a 35 mm-dish) were
incubated for 13 h and washed twice with PBS, then treated
with lysis buffer [protease and phosphatase inhibitors
cocktail (Sigma), 10 mM Tris (pH 7.4), 1% sodium dodecyl
sulfate (SDS), 1 mM sodium vanadate (V)] and the lysates
were sonicated. Denatured proteins (30 μg) were separated
using SDS-polyacrylamide gel electrophoresis on a 10%
polyacrylamide gel and transferred onto Immobilon-P
Transfer Membrane (Millipore, MA). After blocking for 1 h
at room temperature in Block Ace (Dainippon Pharma-
ceutical, Osaka, Japan), the membranes were first incubated
with each antibody at a dilution of 1:1000, followed by a
second incubation performed with horseradish peroxidase-
conjugated secondary anti-rabbit IgG at a dilution of 1:2000.
The blots were developed using ECL Western Blotting
detection reagent (Amersham Biosciences, Buckinghamshire,
UK) and the band intensities were analyzed using NIH
Image. Relative levels of each protein were corrected by α-
tublin as the internal control.
Reverse transcription-PCR
Cells (1.0 × 106 cells/5 ml on a 60-mm dish) were incu-
bated for 13 h, then washed twice with PBS. Total RNA was
extracted using TRIzol® reagent. cDNA was synthesized
using 1 μg of total RNA and an RNA PCR Kit (AMV). PCR
amplification was then performed with a thermal cycler
(PTC-100TM, MJ Research, Watertown, MA), under the
following conditions: CD74; forward (5'-TgACCAg CgC-
gACCTTATCT-3') and reverse (5'-gAgCAggTgCATCA-
CATggT-3') primers (0.05 μM each, product size 384 bp and
560 bp) for 30 cycles, with 60 s of denaturation at 94°C, 90 s
of annealing at 54°C, and 60 s of primer extension at 72°C,
and glyceraldehyde-3-phosphate-dehydrogenase (GAPDH);
forward (5'-GTGAAGGTCGGAGTCAACG-3') and reverse
(5'-GGTGAAGACGCCAGTGGACTC-3') primers (0.05 μM
each, product size 300 bp) for 23 cycles, with 30 s of
denaturation at 95°C, 60 s of annealing at 58°C, and 60 s ofEffects of Food Factors on CD74 Expression
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primer extension at 72°C. Amplified cDNA was subjected to
electrophoresis on 3% agarose gels and stained with SYBR®
Gold. Image analysis was performed using NIH image.
Relative levels of each protein were corrected by GAPDH
transcript, which served as the internal control.
Cell-based ELISA
N87 Gastric carcinoma cells (4 × 104 cells/200 μl) were
seeded onto a 96-well microplate with a clear bottom
(IWAKI, Tokyo) and pre-incubated for 13 h. After incuba-
tion, the medium on the plate was replaced with serum-free
RPMI1640 containing the samples dissolved in dimethyl
sulfoxide (DMSO, final 0.5%, v/v). After 48 h of incubation,
the medium were removed, and the cells were fixed by
replacing the medium with 95% ethanol and 5% acetic acid
for 7 min at room temperature. Subsequently, the solvents
were replaced with 1% formaldehyde in PBS for 5 min at
room temperature. After washing with washing buffer
(0.05% Tween 20 in PBS), quenching buffer (0.6% H2O2 in
wash buffer) was added and incubation was performed for
20 min at room temperature, then blocking buffer (10%
BSA in PBS) was added and incubation performed for 1 h at
37°C. After washing, the plate was incubated with rabbit
anti-CD74 or nonspecific IgG antibody (5 μg/ml, each) for
1 h, and, after washing, horseradish-peroxidase (HRP)
conjugated secondary antibody was added at a dilution of
1:2000 for 1 h. A color reaction was initiated by adding
substrate solution [o-phenylethylenediamine (OPD) in
citrate buffer (1 mg/ml, each)] for 15 min and terminated
with a stop solution (1 N sulfuric acid in PBS). Visible
absorption at 492 nm was recorded using a microplate reader
(Thermo Fisher Scientific, Waltham, MA).
Cell viability
Cell viability was measured using 3-(4,5-dimethyltiazol-
2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) [19]. After
incubation, the cells were washed twice with PBS, then
110 μl of serum-free RPMI1640 containing 10 μl of MTT
solutions (5 mg/ml) were added to each culture, followed by
another incubation at 37°C for 2 h. Next, 200 μl of DMSO
was added and the culture was sonicated for 5 min, after
which 500 μl of HCl/2-propanol (3.4 μl/ml) was added to
each well. Visible absorbance was measured at 570 nm and
630 nm using a microplate reader. Cell viability above 70%
was recognized as significant.
Results
Expression of CD74 in human gastric carcinoma and fetal
gastric cells
Initially, we examined the constitutive expression of
CD74 using western blotting and RT-PCR. As shown in
Fig. 1, we found significantly high levels of constitutive
CD74 expression in NCI-N87 human gastric carcinoma
cells at the protein and mRNA levels of 14- and 6-fold,
respectively as compared to those in Hs738St./Int fetal
gastric cells.
Screening of selected food factors for their effects on CD74
expression using novel cell-based ELISA with N87 cells
A total of 25 food factors (Fig. 2) were selected based on
their previously reported anti-inflammatory in vitro and in
vivo activities [17, 20–22]. Each was subjected to our novel
cell-based ELISA established in the present study. As shown
in Table 1, 65% of the tested compounds exhibited strong
cytotoxicity [cell viability (CV) >70%] at a concentration of
100 μM after 48 h. Subsequently, some of the compounds,
such as curcumin, ACA, and ursolic acid, continued to
induce cytotoxicity (20 μM, CVs = 12%, 20%, and 38%,
respectively). Notably, silymarin (100 μM) and bergamottin
Fig. 1. Constitutive expression of CD74 in NCI-N87 gastric
carcinoma cells (N87) and Hs738St./Int fetal gastric
cells (Hs738). High levels of constitutive CD74 expres-
sion in NCI-N87 human gastric carcinoma cells at the
protein and mRNA levels were observed as compared
with in Hs738St./Int fetal gastric cells. The intensity of
each band was analyzed by Western blotting (A) and RT-
PCR (B), as described in the Materials and Methods
section. The experiments were repeated twice indepen-
dently.H. Sekiguchi et al.
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(20 μM) markedly inhibited CD74 expression [inhibitory
rates (IRs) = 91% and 74%, respectively) without consider-
able cytotoxicity. Further, (−)-catechin, gallic acid,
zerumbone, auraptene, nobiletin, genistein, quercetin, and
luteolin (20 μM) were moderately suppressive (IRs = 40–
65%), while none of the compounds showed marked
suppression at a concentration of 20 μM. As summarized in
Table 2, the IC50 values for zerumbone, auraptene, nobiletin,
quercetin, luteolin, and bergamottin were lower (IC50 =1 4 –
20 μM) than for other compounds. Marginal cytotoxicity
was observed with some compounds, including (−)-catechin
and gallic acid. Based on the LC50/IC50 ratios, we identified
bergamottin as the most promising CD74 suppressant (LC50/
IC50 >7.1), followed by in order by luteolin, nobiletin, and
quercetin (LC50/IC50 >5.4, >5.3, and >5.1, respectively).
Discussion
Several adhesins on the cell surface of H. pylori have been
identified, including BabA, SabA, and AlpA/B. BabA and
SabA bind to Lewis B blood group antigen [23] and Sialyl
Lewis X [24], respectively, while the ligands to AlpA/B
receptors remain unknown [25]. Although they are
associated with the attachment of H. pylori, those receptors
are not recognized as signaling molecules responsible for
activating the immune system in host cells. On the other
hand, cell surface-associated urease, recently identified as
an adhesin of H. pylori, binds to MHC class II molecules
for inducing apoptosis [26]. Further, Beswick et al. reported
that the MHC class II invariant chain, i.e., CD74, plays an
essential role in binding to the urease β subunit of H. pylori
[9, 12].
CD74 is a type II integral membrane protein that func-
tions in signaling pathways for malignant B-cell prolifera-
tion and survival [27, 28]. It is expressed in cancer cells as
well as stomach [29], renal [30], and bladder [31] tissues,
and serves as a marker of tumor progression [32].
Conversely, preclinical studies using anti-CD74 antibodies
have shown that CD74 is an effective therapeutic target for
B-cell malignancy, such as non-Hodgkin lymphoma and
multiple myeloma [33]. It should be pointed out that H.
pylori binding to CD74 on gastric cells stimulated the NF-
κB pathway that leads to IL-8 production [9, 12]. Interest-
ingly, CD74 was also reported to serve as a receptor for
macrophage migration inhibitory factor (MIF), a proinflam-
matory cytokine with versatile functions [34–38]. MIF binds
to the CD74/CD44 complex for activating proliferative and
proinflammatory signaling molecules, such as extracellular
signaling-regulated kinase [39]. Collectively, targeting
CD74 suppression may not only inhibit H. pylori adhesion,
but also mitigate resultant proinflammatory events.
A variety of food phytochemicals and synthetic drugs
Fig. 2. Chemical structures of selected food factors.Effects of Food Factors on CD74 Expression
Vol. 43, No. 2, 2008
113
have been reported to inhibit H. pylori adhesion to gastric
epithelium cells [40]. For example, tea catechins were
shown to decrease H. pylori colonization in Mongolian
gerbils by inhibiting urease [6]. In the present study,
however, EGCG, the most active principle in tea, did not
suppress CD74 expression, but rather enhanced it, while (−)-
catechin was suppressive only at a high concentration
(100 μM). Although ascorbic acid reduced H. pylori coloni-
zation and subsequent inflammation in Mongolian gerbils
[41], it (even at 100 μM) did not suppress CD74 in our
study. On the other hand, a notable CD74 suppressant, citrus
auraptene (LC50/IC50 = 3.0), has been reported to reduce H.
pylori colonization in vivo [42]. It is tempting to speculate
that this reduction is due, at least in part, to CD74 modula-
tion. Interestingly, quercetin (LC50/IC50 >5.1), a potent anti-
oxidative and anti-inflammatory agent in onions, reduced
N-methyl-N’-nitro-N-nitrosoguanidine-induced inflammation
in H. pylori-infected human gastric mucosal cells in a pre-
vious study, though the effects on colonization were not
addressed [43].
Bergamottin, a furanocoumarin occurring in citrus fruit,
was identified as the most promising suppressant in the
present study (LC50/IC50 >7.1). This compound has been
well described to inhibit cytochrome P450 (CYP) 3A4 [44],
CYP1A1 [45], and other CYPs [46]. In addition, berga-
mottin reduced the formation of DNA adducts in MCF-7
cells induced by benzo[a]pyrene and 7, 12-dimethylbenz
[a]anthracene [47], skin tumors in mice [48], and NO
generation [49], while it induced leukemia differentiation
[50]. Furthermore, some case-control studies have suggested
that citrus fruit intake reduces the risk of gastric cancer [51–
54]. In this context, it should be noted that several citrus
compounds, i.e., bergamottin, nobiletin, auraptene, and
tangeretin, exhibited significant activity in the present
assays (Table 2), though their action mechanisms to sup-
press CD74 expression remain unknown. Nonetheless, it
Table 1. Suppressive effects of selected compounds on constitutive CD74 expression in NCI-N87 gastric carcinoma cells
Data are shown as the mean ± average deviation, IR; Inhibition rate, CV; Cell viability, NT; Not tested, ACA; 1'-acetoxychavicol acetate,
BITC; benzyl isothiocyanate, BUGLS; gluconapin, BUITC; butenyl isothiocyanate, EGCG; (−)-epigallocatechin-3-gallate, PEGLS;
gluconasturtiin, PEITC; phenetyl isothiocyanate
4 μM2 0 μM 100 μM
IR (%) CV (%) IR (%) CV (%) IR (%) CV (%)
ACA 16 ± 1.6 92 ± 3.4 NT 20 ± 0.2 NT 6.1 ± 0.3
Ascorbic acid –12 ± 3.5 97 ± 1.7 5.4 ± 3.8 94 ± 0.3 6.8 ± 1.8 86 ± 5.8
Auraptene 2.4 ± 2.0 96 ± 2.7 50 ± 0.4 79 ± 4.5 NT 18 ± 0.4
Bergamottin 8.6 ± 4.2 93 ± 0.0 74 ± 8.2 79 ± 0.0 NT 59 ± 2.1
BITC –19 ± 0.6 96 ± 3.4 NT 56 ± 7.9 NT 6.1 ± 1.3
BUGLS –15 ± 0.0 88 ± 6.9 −19 ± 2.5 80 ± 3.5 4.0 ± 1.0 79 ± 5.6
BUITC –9.0 ± 0.4 71 ± 5.8 2.3 ± 0.8 73 ± 3.3 NT 44 ± 2.4
Caffeine 10 ± 7.7 100 ± 2.6 22 ± 6.9 100 ± 2.2 41 ± 9.2 87 ± 1.9
(−)-Catechin −6.4 ± 2.0 97 ± 2.5 40 ± 2.1 97 ± 3.3 65 ± 0.8 89 ± 5.9
Curucumin 21 ± 8.0 89 ± 1.1 NT 12 ± 1.9 NT 14 ± 6.8
EGCG −110 ± 8.3 78 ± 6.3 −149 ± 3.8 77 ± 3.1 −217 ± 4.0 78 ± 5.0
Ferulic acid −5.1 ± 4.3 96 ± 2.3 15 ± 5.8 93 ± 0.7 20 ± 3.8 82 ± 5.9
Gallic acid 15 ± 2.4 97 ± 0.2 57 ± 3.7 73 ± 2.4 47 ± 8.3 97 ± 2.1
Genistein 8.6 ± 7.8 100 ± 0.4 49 ± 7.2 84 ± 1.5 NT 55 ± 4.6
Luteolin 4.0 ± 5.1 99 ± 2.9 55 ± 1.2 81 ± 4.7 NT 61 ± 1.5
Nobiletin 1.8 ± 2.9 96 ± 0.3 54 ± 5.0 93 ± 0.5 NT 58 ± 5.0
PEGLS −11 ± 4.4 99 ± 1.4 −25 ± 1.3 88 ± 1.7 −13 ± 3.8 90 ± 1.4
PEITC −17 ± 2.3 97 ± 4.8 NT 43 ± 1.8 NT 37 ± 2.2
Quercetin 3.7 ± 0.0 100 ± 3.0 51 ± 4.7 100 ± 3.0 NT 51 ± 0.5
Rutin −4.3 ± 2.8 97 ± 1.2 −3.0 ± 0.0 100 ± 1.1 11 ± 4.5 80 ± 4.7
Silymarin −11 ± 3.6 100 ± 3.2 23 ± 1.9 100 ± 1.4 91 ± 9.2 76 ± 2.2
Tangeretin −3.3 ± 3.3 98 ± 2.7 21 ± 3.1 100 ± 0.5 NT 63 ± 3.1
ar-Turmerone 22 ± 0.5 97 ± 4.1 39 ± 1.8 100 ± 3.2 NT 57 ± 1.3
Ursolic acid 35 ± 6.1 91 ± 1.6 NT 38 ± 1.1 NT 9.7 ± 0.0
Zerumbone 6.6 ± 0.8 100 ± 0.4 57 ± 0.2 77 ± 0.3 NT 16 ± 1.1H. Sekiguchi et al.
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may be helpful to indicate that the a CD74 cytosolic frag-
ment is released for stimulating Syk and Akt, which, in turn,
directly activate NF-κB and its co-activator, TAFII105 [27,
55]. Along a similar line, cell-surface CD74 initiates a
signaling cascade resulting in NF-κB activation for inducing
IL-8 production. Furthermore, H. pylori and the urease β-
subunit were reported to activate NF-κB for increasing
CD74 expression at mRNA and protein levels in NCI-N87
and Kato III gastric carcinoma cells [9, 12, 56]. It is also
interesting to note that CagA-positive H. pylori contributes
to the production of MIF, though its mechanism of action has
not been reported [57]. In addition, several reports have
suggested that MIF up-regulates the NF-κB pathway [28,
58–60]. Taken together, NF-κB activation is considered to
have a major role in CD74 expression. Another study found
that genistein (LC50/IC50 >4.9) decreased NF-κB activation
in MKN45 gastric carcinoma cells co-cultured with H.
pylori [61], which might be partly related to modulation of
CD74 expression. Also, luteolin (LC50/IC50 >5.4) [62],
nobiletin (LC50/IC50 >5.3) [20], quercetin (LC50/IC50 >5.1)
[63], and zerumbone (LC50/IC50 =3 . 4 )  [ 64] have been
reported to markedly inhibit NF-κB in several cell lines.
Thus, the relevance of NF-κB activation in regard to CD74
expression in NCI-N87 cells should be addressed in the near
future.
In conclusion, we established a novel ELISA system for
identifying CD74 suppressive agents using NCI-N87 gastric
cancer cells. The present results suggest that several
compounds including bergamottin are candidates for treat-
ment of H. pylori infection and additional in vivo evaluations
are warranted.
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